LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, has initiated the next phase of its business relationship with Therakos, Inc., a global leader in advancing the science of extracorporeal photopheresis (ECP). Terumo BCT will now be the exclusive distributor in Argentina, Chile, Colombia, Mexico, Uruguay and Peru of the THERAKOS® UVAR XTS® Photopheresis System (XTS) and the THERAKOS® CELLEX® Photopheresis System (Cellex), which physicians use to treat patients with diseases of the immune system.
Help employers find you! Check out all the jobs and post your resume.